Jingxin Li, PhD

Vaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, China

Dr. Li graduated from Department of Pharmacy, Third Military Medical University. She participated in a series of clinical trials of novel vaccines, including Enterovirus type 71 vaccine, recombinant human Ad5 vectored Ebola vaccine, and helicobacter pylori vaccine.

She published 26 SCI articles as co-author, including 2 published in the New England Journal of Medicine and 4 in the Lancet. She has published 11 SCI articles as the first author in the past 5 years, including one published in the Lancet Globe Health.